ArticleAntimicrobial agents and chemotherapy1999

A new point mutation (P157S) in the reverse transcriptase of human immunodeficiency virus type 1 confers low-level resistance to (-)-beta-2',3'-dideoxy-3'-thiacytidine.

R A Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.